NCT01425567Approved For Marketing不适用
Compassionate Use of an Intravenous Lipid Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in Children
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
- 试验地点
- 1
研究概览
简要总结
To establish a process by which critically ill infants with parenteral nutrition-associated liver disease can receive a fish oil-based intravenous lipid emulsion (Omegaven®) for compassionate use when no satisfactory alternative treatments are available.
详细描述
Patients who meet the inclusion criteria (having a direct bilirubin ≥4.0 mg/dL) and are consented will be discontinued from standard soybean-based lipid emulsion and started on Omegaven®. Omegaven® will be infused continuously via either a peripheral or central catheter at a dose of 1 gm/kg/day along with parenteral nutrition (PN).
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 14 Days 至 24 Months(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- •Congenital lethal condition (e.g. Trisomy 13) Clinically severe bleeding Evidence of viral hepatitis or primary liver disease as etiology of their cholestasis Other health problems such as survival extremely unlikely even if cholestasis improves Known allergies to eggs or shellfish
研究者
研究点 (1)
Loading locations...
相似试验
Approved For Marketing
不适用
Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in InfantsTotal Parenteral Nutrition-induced CholestasisNCT02534077Pediatrix
已完成
不适用
Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in InfantsCholestasisCholestasis of Parenteral NutritionNCT00738101Baylor College of Medicine293
终止
1 期
SMOFlipid to Lessen the Severity of Neonatal CholestasisCholestasisJaundice, ObstructiveNCT02721277University of Florida2
已完成
4 期
Lipid Emulsions and Liver Function - Results After 5 Years.Parenteral Nutrition-Related HepatitisLiver FailureNCT04347902Stanley Dudrick's Memorial Hospital65
Unknown
不适用
SMOF Lipid for Children With Parenteral Nutrition Induced Liver InjuryCholestasisGrowth FailureNCT02412566Baylor College of Medicine
